# Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD

> **NCT03480997** · PHASE1 · COMPLETED · sponsor: **Pneuma Respiratory, Inc** · enrollment: 46 (actual)

## Conditions studied

- COPD

## Interventions

- **COMBINATION_PRODUCT:** Albuterol Sulfate and Ipratropium Bromide
- **COMBINATION_PRODUCT:** Albuterol Sulfate

## Key facts

- **NCT ID:** NCT03480997
- **Lead sponsor:** Pneuma Respiratory, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-27
- **Primary completion:** 2017-04-28
- **Final completion:** 2017-04-28
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03480997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03480997, "Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03480997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*